For the Inventor, By the Inventor

Enter assignee name

Xiamen University

USPTO Granted Patents = 165

% Expired Patents = 10.9

CIPO Patents = 3

EPO Patents = 39

Trademarks = 1

Forward Citations = 121

Loading Chart...

Loading Chart...

547 inventors (with patents filed for the assignee):

Ningshao Xia (56 out of 58 patents)

Jun Zhang (33 out of 114 patents)

Shaowei Li (26 out of 28 patents)

4. Ying Gu (15 out of 17 patents)

5. Lizong Dai (12 out of 12 patents)

6. Shengxiang Ge (12 out of 15 patents)

7. Birong Zeng (11 out of 11 patents)

8. Yiting Xu (11 out of 11 patents)

9. Quan Yuan (11 out of 12 patents)

10. Wenxin Luo (10 out of 10 patents)

11. Xianming Deng (8 out of 30 patents)

12. Conghui Yuan (8 out of 8 patents)

13. Wei'ang Luo (7 out of 7 patents)

14. Tianying Zhang (7 out of 7 patents)

15. Yixin Chen (7 out of 7 patents)

Core Competencies:

Optical Imaging Device

Vaccine Adjuvant

Virus Treatment

Optical System

Micro-Nanoparticle

Fluorescent Material

Deep Learning

Magnetic Resonance Imaging

Antimicrobial Peptide

Data Verification

Acoustic Communication

Graphene Material

165 patents: Sort by Forward Citations

1. 12736676 - System and method of capturing large scale scenes using wearable inertial measurement devices and light detection and ranging sensors (2026-09-15),

2. 12736543 - ANTIGEN FOR 2019 NOVEL CORONAVIRUS AND DETECTION USE THEREOF (2026-09-15),

3. 12735806 - Method for sic step flow growth by regulating growth monmoers using chemical potential under non-equilibrium condition (2026-09-15),

4. 12715941 - Metallocene compound, and preparation method therefor and application thereof (2026-08-25),

5. 12703880 - METHOD FOR ASYMMETRIC AMPLIFICATION OF MULTIPLE TARGET NUCLEIC ACIDS (2026-08-11),

6. 12697383 - MODIFIED ENVELOPE PROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS AND USE THEREOF (2026-08-04),

7. 12691175 - Drug transdermal delivery system (2026-07-28),

8. 12655088 - Compound for treating Alzheimer's disease (2026-06-16),

9. 12607840 - Objective lens, optical imaging device, optical system, and test method of optical system (2026-04-21),

10. 12600750 - METHODS FOR INACTIVATING AND STORING RESPIRATORY SYNCYTIAL VIRUS (2026-04-14),

11. 12570597 - Polyaryl carboxylic fullerene derivative and use thereof in anti-coronavirus infection (2026-03-10),

12. 12569468 - Use of palovarotene in treatment against HBV virus (2026-03-10),

13. 12504418 - Method for early warning of algal bloom levels based on Ordinal Forests model (2025-12-23),

14. 12472250 - Preparation of zinc zoledronate micro-nanoparticle adjuvant and use thereof as vaccine adjuvant (2025-11-18),

15. 12463006 - Transmission electron microscope high-resolution in situ fluid freezing chip (2025-11-04),

Company Overview

Xiamen University, located in Xiamen, China, is a prominent institution known for its advanced research in optical imaging and related technologies. The university specializes in the development of optical imaging devices, vaccine adjuvants, and innovative treatments for viral infections. Its research encompasses a range of core technology topics, including micro-nanoparticles, fluorescent materials, and deep learning applications in medical imaging, particularly magnetic resonance imaging. Xiamen University is committed to fostering technological advancements and contributing to the global scientific community.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

165 Patents

#5 in Xiamen

#204 in China

#5,008 in the World

Xiamen University

Forward Citations = 121

547 inventors:

Ningshao Xia (56 out of 58 patents)

Jun Zhang (33 out of 114 patents)

Shaowei Li (26 out of 28 patents)

4. Ying Gu (15 out of 17 patents)

5. Lizong Dai (12 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Xiamen University. Retrieved from https://idiyas.com/company/xiamen-university

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…